Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2026 12:30 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel

Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel Paris, le 4 mars 2026. Sanofi annonce avoir déposé ce jour un amendement à son Document...
March 04, 2026 12:30 ET | Source: Sanofi Winthrop Industrie

Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report

Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, March 4, 2026. Sanofi announces today the filing of an amendment to its...
March 04, 2026 07:30 ET | Source: NervGen Pharma Corp.

NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs

VANCOUVER, British Columbia, March 04, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing...
March 03, 2026 17:00 ET | Source: Teva Pharmaceutical Industries Ltd

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting TL1ADuvakitug is currently in phase 3 clinical studies for ulcerative...
March 03, 2026 12:07 ET | Source: Euroapi

Résultats 2025 : amélioration de la marge de Core EBITDA en dépit de vents contraires sur l’activité, grâce à une stricte discipline financière

Communiqué de presseParis, le 3 mars 2026 Avancée de FOCUS-27 dans un environnement plus difficile Accélération de la transformation pour renforcer le modèle opérationnel Résultats 2025 Chiffre...
March 03, 2026 12:07 ET | Source: Euroapi

2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline

Press Release Paris, 3rd March, 2026 Progress against FOCUS-27 in a deteriorating environment Accelerated transformation to strengthen the operating model Full-year 2025 results €848.2 million...
March 03, 2026 09:51 ET | Source: 24/7 Market News

Defense Supply Chains and Strategic Materials Drive the Morning Bid

The morning tape is leaning decisively toward defense-linked manufacturers, advanced materials innovators, and capital-raising energy names
March 03, 2026 09:40 ET | Source: Research and Markets

7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Asthma - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The asthma market in the...
March 03, 2026 04:24 ET | Source: Research and Markets

AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "AI in Pharma Manufacturing Market, till 2040: Distribution by Type of Offering, Mode of Deployment, Type of AI Solution, Type of Technology,...
March 02, 2026 12:17 ET | Source: Société Générale

Société Générale : Renouvellements et nominations d’administrateurs proposés à l’Assemblée générale du 27 mai 2026

RENOUVELLEMENTS ET NOMINATIONS D’ADMINISTRATEURS PROPOSÉS À L’ASSEMBLÉE GÉNÉRALE DU 27 MAI 2026 Communiqué de presseParis, le 02 mars 2026 Le Conseil d’administration, sur proposition du Comité des...